NCT07529847 Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
| NCT ID | NCT07529847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Asthma (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2026-02-28 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2026-02-28 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Eligibility Criteria
Inclusion Criteria: * Age between 18-45 years * Both genders (male and female) * Grade 1-3 on mMRC scale of dyspnea * Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020) Exclusion Criteria: * Patients having acute exerbation of COPD/status asthmaticus * Patients diagnosed with acute infection * Patients unable to follow command and instructions * Asthma patients with \>40sec control pause duration
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07529847 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Asthma (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07529847 currently recruiting?
Yes, NCT07529847 is actively recruiting participants. Contact the research team at maryamarooj418@gmail.com for enrollment information.
Where is the NCT07529847 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07529847 clinical trial?
NCT07529847 is sponsored by Foundation University Islamabad. The trial plans to enroll 46 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.